Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012)
Bausch Health Companies (BHC) posted Change in Account Payables of -$9.9 million for Q1 2012, up 35.91% sequentially from -$15.5 million in Q4 2011, and up 73.76% YoY from -$5.7 million in Q2 2011.
Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012) Analysis & Trends
Bausch Health Companies has reported Change in Account Payables for 4 years, with the latest figure at -$9.9 million in Q1 2012.
- Quarterly Change in Account Payables rose 73.76% year-over-year to -$9.9 million in Q1 2012, while the trailing twelve-month figure through Mar 2012 was $18.9 million (up 122.46% YoY) and the FY2011 annual result came in at -$9.0 million, up 88.2% from the prior year.
- Change in Account Payables climbed to -$9.9 million in Q1 2012 per BHC's latest filing, from -$15.5 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $34.1 million in Q4 2009 and troughed at -$68.1 million in Q4 2010.
- A 4-year average of -$4.0 million and a median of $2.8 million in 2009 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2010 and 2011: Change in Account Payables plunged 299.6% in 2010, then soared 4958.13% in 2011.
- Over 4 years, Change in Account Payables stood at $34.1 million in 2009, then slumped by 299.6% to -$68.1 million in 2010, then surged by 77.26% to -$15.5 million in 2011, then surged by 35.91% to -$9.9 million in 2012.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$9.9 million, -$15.5 million, and $16.8 million for Q1 2012, Q4 2011, and Q3 2011 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | -9.92 Mn |
| Mar 31, 2012 | -9.92 Mn |
| Dec 31, 2011 | -15.48 Mn |
| Dec 31, 2011 | -15.48 Mn |
| Sep 30, 2011 | 16.81 Mn |
| Sep 30, 2011 | 16.81 Mn |
| Jun 30, 2011 | 27.50 Mn |
| Jun 30, 2011 | 27.50 Mn |
| Mar 31, 2011 | -37.81 Mn |
| Mar 31, 2011 | -37.81 Mn |
| Dec 31, 2010 | -68.08 Mn |
| Dec 31, 2010 | -68.08 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Jun 30, 2010 | -566,000.00 |
| Jun 30, 2010 | -566,000.00 |
| Mar 31, 2010 | -29.73 Mn |
| Mar 31, 2010 | -29.73 Mn |
| Dec 31, 2009 | 34.11 Mn |
| Dec 31, 2009 | 34.11 Mn |